Defunct Company
Total Trials
18
As Lead Sponsor
15
As Collaborator
3
Total Enrollment
521
NCT01438853
Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2004
Completion: Feb 29, 2008
NCT00496860
Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies
Start: May 31, 2007
Completion: Oct 31, 2009
NCT00879606
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Phase: Phase 2
Start: Apr 30, 2009
Completion: Jan 31, 2013
NCT01029873
QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma
Phase: Phase 1/2
Start: Feb 28, 2010
Completion: Sep 30, 2013
NCT01325558
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Start: May 31, 2011
Completion: Feb 28, 2015
NCT01326871
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Start: Sep 6, 2011
Completion: Apr 11, 2016
NCT01478074
ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia
Start: Nov 30, 2011
Completion: Nov 30, 2013
NCT01625260
A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
Start: Mar 30, 2012
Completion: Mar 8, 2018
NCT01670994
QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma
Start: Aug 14, 2012
Completion: Sep 9, 2015
NCT01946789
A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors
Start: May 31, 2014
Completion: Dec 31, 2017
NCT02099539
QUILT-3.005: A Study of N-803 in Patients With Relapsed or Refractory Multiple Myeloma
Start: Oct 6, 2014
Completion: Jun 19, 2018
NCT02384954
QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab
Start: Apr 17, 2015
Completion: Dec 13, 2020
NCT02523469
ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer
Role: Collaborator
Start: Jan 8, 2016
Completion: Feb 24, 2023
NCT02559674
QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Paclitaxel
Start: Jul 31, 2016
Completion: Feb 21, 2018
NCT03381586
QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803
Start: Dec 27, 2017
Completion: Mar 13, 2018
NCT03003728
2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)
Start: Nov 1, 2019
Completion: Jul 8, 2020
NCT04142359
PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)
Phase: N/A
Start: Dec 9, 2019
Completion: Apr 6, 2020
NCT04290546
CIML NK Cell in Head & Neck Cancer
Start: Jul 20, 2020
Completion: Dec 16, 2024